EricARoseMD
Thoracic Surgery • New York, NYCardiovascular Surgery
Professor, Health Evidence & Policy, Surgery,Cardiothoracic Surgery, and Medicine, Icahn School of Medicine at Mount Sinai
Dr. Rose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
35 E 62nd St
New York, NY 10065Phone+1 212-572-5163Fax+1 212-572-5164
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 1975 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1975
Certifications & Licensure
NY State Medical License 1977 - 2026
NJ State Medical License 1997 - 2013
VA State Medical License 2006 - 2010- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 154 citationsRandomized, Double-Blind Trial of Inhaled Nitric Oxide in LVAD Recipients With Pulmonary HypertensionMichael Argenziano, Asim F. Choudhri, Nader Moazami, Eric A. Rose, Craig R. Smith
The Annals of Thoracic Surgery. 1998-02-01 - 140 citationsTwo-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.Daniel Goldstein, Alan J Moskowitz, Annetine C Gelijns, Gorav Ailawadi, Michael K Parides
The New England Journal of Medicine. 2016-01-28 - 267 citationsManagement of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agentMichael Argenziano, Jonathan M. Chen, Asim F. Choudhri, Suzanne Cullinane, Evan Garfein
The Journal of Thoracic and Cardiovascular Surgery. 1998-12-01
Press Mentions
Mesoblast Limited (NASDAQ:MESO) Q2 2023 Earnings Call TranscriptMarch 6th, 2023- Mesoblast Limited (MESO) Q4 2022 Earnings Call TranscriptAugust 31st, 2022
- Appendix 4C Quarterly Activity ReportMesoblast Operational and Financial Highlights for Quarter Ended March 31, 2022April 29th, 2022
- Join now to see all
Grant Support
- Stem Cell Repair Of Native Hearts In LVAD PatientsNational Heart, Lung, And Blood Institute2005–2008
- Network For Cardiothoracic Surgical Investigations In Cardiovascular MedicineNational Heart, Lung, And Blood Institute2007
- Biology Of Long-Term Mechanical Circulatory SupportNational Heart, Lung, And Blood Institute2005–2007
- Rematch TrialNational Heart, Lung, And Blood Institute1997–2001
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
